Skip to content
★ Sign in to follow
KP

Kissei Pharmaceutical Co.,Ltd. Stock: price and insider trades · Japan

キッセイ薬品工業株式会社

JP·Mcap JP¥157.3BHealth Care

Kissei Pharmaceutical Co.,Ltd.: what insiders have been doing

Insider filings for Kissei Pharmaceutical Co.,Ltd. are scarce in the EDINET (Japan FSA) feed, the latest one published on 20 May 2024. This page will fill in as new trades are disclosed. Every figure here comes from the filings published by EDINET (Japan FSA) and describes the past, not future prices; it is not investment advice.

Insider Decl.
4
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a

Analyst consensus: bullish or bearish?

Analysts rate Kissei Pharmaceutical Co.,Ltd. Buy (bullish), based on 6 analysts. Average price target: JP¥4,567.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 5,643 of 26,897 companies
66.4
score / 100
Value
60
Quality
73
FCF yld-4.5%
Earn yld8.8%
EV/EBITDA7.4x
ROE6.5%
Gross mgn47%
Net mgn14%
Debt/EBITDA0.1x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2026

FY ended March 2026 · cache

JP¥3,760
Analyst consensus
6 analysts
Buy
JP¥4,000Target JP¥4,567(+21%)JP¥5,500
Income statement
RevenueJP¥97.4B
Gross profitJP¥45.8B47% margin
EBITDAJP¥21.6B22% margin
Net incomeJP¥13.8B14.2% margin
Valuation
PER (trailing)11.2x
P/Book0.7x
Beta-0.14
Balance sheet & cash
Market capJP¥157.3B
Total debtJP¥1.3B
Free Cash Flow-JP¥7.1B
Debt / Equity1%
Profitability & ownership
ROE6.5%
ROA-1.0%
% insiders21.7%
% institutions24.1%
Last declaration on 20 May 2024
Declarations4 total

4 of 4 declarations

About Kissei Pharmaceutical Co.,Ltd.

Kissei Pharmaceutical Co., Ltd. is a Japanese company operating in the healthcare and pharmaceutical sector. It focuses on the research, development, and marketing of innovative medicines.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations